Tessera Multimedia participated in the 2nd Model School of Advanced Skills in Pathology, which took place in Mouzaki, Karditsa, from February 27, 2026 , to March 1, 2026.
As part of the conference, the company’s General Director delivered a presentation titled “Artificial Intelligence and Technology Applications in Pathology“, highlighting the role of digital technologies in modern medicine.
The presentation focused on understanding artificial intelligence (AI) and how it can be utilized in everyday clinical practice. More specifically, the capabilities of digital tools for the management of chronic diseases were presented, with particular emphasis on diabetes.
In Pathology, artificial intelligence can be used to analyze laboratory data, predict and assess risk, and provide timely alerts to healthcare professionals. In this way, technology contributes to improving the quality of patient care and reducing the time spent on administrative processes.
As part of the presentation, the digital platform forDiabetes was also introduce, which enables the remote monitoring of patients with diabetes mellitus. The application allows users to record key health measurements, generate reports, and exchange data with the treating physician, enhancing patient engagement in the management of the disease.
The evolution of the platform through the DiabForeAI research project, which will leverage artificial intelligence technologies to predict hypoglycemic episodes, automatically detect patterns, and provide personalized alerts to users.
The presentation highlighted the significant potential of artificial intelligence in medicine, while also emphasizing that technology acts as a supportive tool for the scientist. Its responsible use, combined with scientific evidence and human oversight, constitutes a fundamental prerequisite for its application in clinical practice.
The project “Innovative Digital System for Hypoglycemia Prediction and Diabetes Self-Management Using Artificial Intelligence Technologies” is implemented within the framework of the “Research – Innovate” Action and is co-financed by Greece and the European Union (European Regional Development Fund – ERDF) through the NSRF 2021–2027.